Elevated Serum Creatinine and a Normal Urinalysis: A Short Differential Diagnosis in the Etiology of Renal Failure

REFERENCES

• Hebert LA, Wilmer WA, Falkenhain ME, et al. Renoprotection: one or many therapies?. Kidney Int 2001; 59: 1211–1226, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jafar RH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. Ann Intern Med 2001; 135: 73–87, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Roubicek C, Brunet P, Huiart L, et al. Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis 2000; 36: 35–41, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Obrador GT, Ruthazer R, Arora P. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 1999; 10: 1793–1800, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Arora P, Obrador GT, Ruthazer R, et al. Prevalence, predictors and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 1999; 10: 1281–1286, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kausz AT, Khan SS, Abichandani R, et al. Management of patients with chronic renal insufficiency in the northeastern United States. J Am Soc Nephrol 2001; 12: 1501–1507, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Int Med 2002; 137: 479–486, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kramer HJ, Nguyen QD, Curhan G, Hsu C. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289: 3273–3277, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brenner BM. The Kidney5^th. WB Saunders Company, Philadelphia 1996; 1942
   Google Scholar
• Rose BD. Pathophysiology of Renal Disease2^nd. McGraw-Hill, New York 1987; 45: 261
   Google Scholar
• Wynckel A, Ebikili B, Melin JP, et al. Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors. Am J Hypertension 1998; 11: 1080–1186, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Esmail ZN, Loewen PS. Losartan as an alternative to ACE inhibitors in patients with renal dysfunction. Ann Pharmacother 1998; 32: 1096–1098, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Delmas PD. Non-steroidal anti-inflammatory drugs and renal function. Br Soc of Rheumatol 1995; 34(Suppl 1)25–28, [CSA]
   PubMedGoogle Scholar
• Murray MD, Black PK, Kusmik DD, et al. Acute and chronic effects of nonsteroidal anti-inflammatory drugs on glomerular filtration rate in elderly patients. Am J Med Sci 1995; 310: 188–197, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Segev A, Ben-Chirit S, Orion Y. Acute eosinophilic interstitial nephritis and uveitis (TINU syndrome) associated with granulomatous hepatitis. Clin Nephrol 1999; 5: 310–313, [CSA]
   Google Scholar
• Scully RE, Galdabini JJ, McNeely BU. Case records of the Massachusetts General Hospital. N Engl J Med 1981; 304: 33–43, [CSA]
   PubMedGoogle Scholar
• Scully RE, McNeely BU. Case records of the Massachusetts General Hospital. N Engl J Med 1974; 291: 406–412, [CSA]
   PubMedGoogle Scholar
• Smith MC, Ghose MK, Henry AR. The clinical spectrum of renal cholesterol embolism. Am J Med 1981; 71: 174–180, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McGowan JA, Greenberg A. Cholesterol atheroembolic renal disease. Am J Nephrol 1986; 6: 135–139, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Cremer W, Bock KD. Symptoms and course of chronic hypokalemic nephropathy in man. Clin Nephrol 1977; 7: 112–119, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Feinstein EI, Zawada ET, Sanderson EW, Rossing D, Ohrt D, Simmons J. Hypercalcemia and acute renal insufficiency in a 24-year-old white male with lung disease. Am J Nephrol 1986; 6: 152–157, [CSA]
   PubMedGoogle Scholar
• Galler M, Folkert VW, Schlondorff D. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. JAMA 1981; 246: 154–155, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Favre L, Glasson P, Vallotton MB. Reversible acute renal failure from combined triamterene and indomethacin. Ann Intern Med 1982; 96: 317–320, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fawaz-Estrup F, Ho G. Reversible acute renal failure induced by indomethacin. Arch Intern Med 1981; 141: 1670–1671, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Gitlin M. Lithium and the kidney. Drug Saf 1999; 20: 231–243, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Markowitz GS, Radhakrishnan J, Kambham N, et al. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 2000; 11: 1439–1448, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Singer I. Lithium and the kidney. Kidney Int 1981; 19: 374–387, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• McDonald CJ, Overhage JM, Tierney W, et al. The Regenstrief medical record system: a quarter century experience. Int J Med Informatics 1999; 54: 225–253, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cabaluna CC, Gary NE, Eisinger RP. Urinalysis in patients on chronic hemodialysis. Urology 1977; 10: 103–104, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Kirchner FK, Braren V, Smith C, et al. Renal carcinoma discovered incidentally by arteriography during evaluation for hypertension. J Urol 1976; 115: 643–645, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Gibbons RP, Montie JE, Correa RJ, Mason JT. Manifestations of renal cell carcinoma. Urology 1976; 8: 201–206, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Choyke PL, White EM, Zeman RK, Jaffe MH, Clark LR. Renal metastases: clinicopathologic and radiologic correlation. Radiology 1987; 162: 359–363, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Javor KA, Kotsanos JG, McDonald RC, et al. Diabetic ketoacidosis charges relative to medical charges of adult patients with type 1 diabetes. Diabetes Care 1997; 20: 349–354, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pereira BJ. Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 2000; 57: 351–365, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Breyer-Lewis J, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461–470, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Chavers B, Rosenberg M, Foley R, Swan S. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. AJKD 2002; 39(Suppl 1)S76–S92, [CSA]
   PubMedGoogle Scholar
• Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effective analysis. JAMA 2003; 290: 3101–3114, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar